🇺🇸 FDA
Pipeline program

Cannabidiol (Epidiolex)

STUDY001072

Approved small_molecule completed

Quick answer

Cannabidiol (Epidiolex) for Study the Efficacy of Epidiolex for Typical Absence Seizures is a Approved program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).

Program details

Company
Jazz Pharmaceuticals plc
Indication
Study the Efficacy of Epidiolex for Typical Absence Seizures
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials